
Research Support for New Products and Services
Align clinical innovation with reimbursement success through expert billing research support.

What is included in this service?
Deep10x’s Research Support for New Products and Services helps healthcare innovators bring cutting-edge treatments and therapies to market with billing strategies that are payer-ready from day one.
We work with clinical researchers, device manufacturers, and specialty providers to develop CPT/HCPCS coding pathways, simulate reimbursement scenarios, and ensure compliant billing frameworks for emerging therapies — such as skin substitutes, NPWT, biologics, and other advanced treatments.
From early-stage strategy to post-launch support, Deep10x bridges the gap between clinical value and billing reality, ensuring your innovations generate sustainable revenue.
Capabilities:
Our team combines regulatory insight, coding expertise, and payer intelligence to guide the commercialization and billing readiness of new healthcare products.
Capabilities include:
- Coding strategy development (CPT, HCPCS, ICD) for novel therapies
- Reimbursement simulation and financial modeling
- Medical necessity research and documentation templates
- Crosswalks and billing guidance for existing payer coverage policies
- Advisory on claim formats (CMS-1500, UB-04) and revenue code alignment
- Support for pilot testing and limited launch billing workflows
- Post-launch optimization of billing outcomes and coding refinements
Benefits:
Partnering with Deep10x ensures your new product or service has a compliant, effective billing foundation before it reaches the market.
You will gain:
- Increased reimbursement success at launch
- Faster payer adoption through accurate billing strategies
- Reduced coding errors and denial risks for novel procedures
- A research-backed path from innovation to income
- Custom workflows that align with your business model and product type
- Greater confidence in payer conversations and audits
At Deep10x, we don’t just support billing — we help shape the financial success of clinical innovation.